31142-3

Cefepime [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)

Active

Term Description

Susceptibility of an isolate to cefepime in the context of a patient with meningitis, i.e., the "meningitis breakpoint". Various agencies, including the FDA and CLSI in the U.S. and EUCAST in Europe, publish guidelines for determining susceptibility of different organisms to different antimicrobials. In most cases, susceptibility does not vary by type of infection, but for a few specific types of infection, including meningitis, pneumonia and urinary tract infection, certain antimicrobials have different susceptibility thresholds.
Source: Regenstrief LOINC

Part Descriptions

LP17165-9   Cefepime
Cefepime is a fourth-generation cephalosporin antibiotic developed in 1994. It has an extended spectrum of activity against Gram-positive and Gram-negative bacteria. Cefepime hydrochloride was first introduced in 1994 and is currently marketed under various trade names including Maxipime (Elan Pharma, Maxcef, Cepimax, Cepimex, and Axepim). Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Cefepime (Wikipedia)

LP234793-0   Isolate.meningitis
Various agencies, including the FDA and CLSI in the U.S. and EUCAST in Europe, publish guidelines for determining susceptibility of different organisms to different antimicrobials. In most cases, susceptibility does not vary by infection site, but for a few specific types of infection, including meningitis, pneumonia and urinary tract infection, certain antimicrobials have different susceptibility thresholds, which are called "breakpoints". For terms in LOINC that represent specific breakpoints, the LOINC System will indicate the type of infection that the breakpoint is based on, for example, Isolate.meningitis, Isolate.pneumonia, and Isolate.UTI. Source: Regenstrief LOINC

Fully-Specified Name

Component

Cefepime

Property

Susc

Time

Pt

System

Isolate.meningitis

Scale

OrdQn

Method

MIC

Additional Names

Long Common Name

Cefepime [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)

Short Name

Cefepime Islt.mening MIC

Display Name

Cefepime MIC (Isolate.meningitis) [Susc]

Consumer Name Alpha Get Info

Susceptibility to Cefepime

Basic Attributes

Class

ABXBACT

Type

Laboratory

First Released

Version 2.07

Last Updated

Version 2.58

Change Reason

Moved "meningitis" from Component to System to more accurately represent that the concept means antimicrobial susceptibility result for a patient with meningitis rather than susceptibility result for a meningitis form of the antibiotic.

Order vs. Observation

Observation

Member of these Panels

Language Variants Get Info

Related Names

• ANTIBIOTIC SUSCEPTIBILITIES
• AST
• Cefipime
• ID
• Infectious Disease
• InfectiousDisease
• Islt
• Islt.mening
• Isol
• Maxipime
• Mening
• Minimum inhibitory concentration
• Point in time
• Random
• Sus
• Suscept
• Susceptibilities
• Susceptibility
• Susceptibilty

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=31142-3

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.